| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2022 | 2022-08-08 | Future report Set alerts | |
| Q3 2022 | 2022-05-10 | 0.00 | 0.00 |
| Q2 2022 | 2022-02-09 | 0.00 | 0.00 |
| Q1 2022 | 2021-11-09 | 0.22 | 0.22 |
| Q4 2021 | 2021-08-10 | 0.27 | 0.27 |
| Q3 2021 | 2021-05-04 | 0.27 | 0.27 |
| Q2 2021 | 2021-02-02 | 0.30 | 0.30 |
| Q1 2021 | 2020-11-05 | 0.00 | 0.00 |
| Q4 2020 | 2020-08-06 | 0.26 | -0.07 |
| Q3 2020 | 2020-05-06 | 0.27 | -0.18 |
| 2016-06-28 | Initiated Coverage | First Analysis | Overweight | $27.00 |
| 2016-06-01 | Reiterated Rating | Barrington Research | Outperform | $30.00 |
| 2016-04-30 | Reiterated Rating | Canaccord Genuity | Hold | |
| 2016-04-29 | Downgrade | William Blair | Outperform to Market Perform | |
| 2016-04-29 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2016-04-29 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | |
| 2016-01-29 | Boost Price Target | Raymond James | Outperform | $30.00 to $34.00 |
| 2016-01-27 | Reiterated Rating | William Blair | Outperform | |
| 2015-12-14 | Reiterated Rating | William Blair | Outperform | |
| 2015-10-30 | Downgrade | Craig Hallum | Buy to Hold | $31.00 to $28.00 |
| 2015-10-30 | Reiterated Rating | Canaccord Genuity | Hold | $28.00 |
| 2015-08-17 | Reiterated Rating | Canaccord Genuity | Hold | $28.00 |
| 2015-06-12 | Reiterated Rating | Canaccord Genuity | Hold | $28.00 |
| 2015-05-01 | Boost Price Target | Canaccord Genuity | Hold | $26.00 to $28.00 |
| 2015-02-01 | Reiterated Rating | Canaccord Genuity | Hold | $26.00 |
| 2015-01-30 | Upgrade | Craig Hallum | Hold to Buy | |
| 2015-01-16 | Reiterated Rating | Barrington Research | Outperform | $30.00 to $66.70 |
| 2015-01-15 | Upgrade | Stephens | Equal Weight to Overweight | |
| 2014-11-04 | Reiterated Rating | Barrington Research | Outperform | $40.00 |
| 2014-10-31 | Downgrade | Canaccord Genuity | Buy to Hold | $38.00 to $28.00 |
| 2014-10-31 | Reiterated Rating | Needham & Company LLC | Buy | |
| 2014-10-31 | Downgrade | Raymond James | Strong-Buy to Outperform | $37.00 to $32.00 |
| 2014-08-14 | Reiterated Rating | Off Wall Street | Sell | |
| 2014-08-13 | Reiterated Rating | Needham & Company LLC | Buy | $39.00 to $35.00 |
| 2014-05-02 | Reiterated Rating | Raymond James | Strong-Buy | $37.00 |
| 2014-05-02 | Lower Price Target | Canaccord Genuity | $40.00 to $38.00 | |
| 2014-04-02 | Boost Price Target | Canaccord Genuity | $38.00 to $40.00 | |
| 2013-11-18 | Upgrade | Raymond James | Outperform to Strong-Buy | $36.00 to $41.00 |
| 2013-11-04 | Downgrade | Stephens | Overweight to Equal Weight | |
| 2013-11-01 | Boost Price Target | Needham & Company LLC | Buy | $35.00 to $36.00 |
| 2013-08-21 | Reiterated | Needham | Buy | $35 to $30 |
| 2013-01-31 | Reiterated | Canaccord Genuity | Buy | $26 to $34 |
| 2012-10-04 | Downgrade | Avondale | Mkt Outperform to Mkt Perform | $26 to $26 |
| 2012-01-10 | Initiated | Avondale | Mkt Perform | $24 |
| 2011-10-05 | Resumed | Needham | Buy | $25 |
| 2009-07-02 | Initiated | Barrington Research | Outperform | $13 |
| 2008-06-06 | Upgrade | DA Davidson | Neutral to Buy | $13 to $15 |
| 2008-04-25 | Downgrade | DA Davidson | Buy to Neutral | $16 to $13 |
| 2008-03-04 | Downgrade | Canaccord Adams | Buy to Hold | $17 to $14 |
| 2007-04-26 | Reiterated | Canaccord Adams | Buy | $14 to $15 |
| 2007-01-25 | Upgrade | DA Davidson | Neutral to Buy | $11 to $15 |
| 2016-06-28 | Initiated Coverage | First Analysis | Overweight | $27.00 |
| 2016-06-01 | Reiterated Rating | Barrington Research | Outperform | $30.00 |
| 2016-04-30 | Reiterated Rating | Canaccord Genuity | Hold | |
| 2016-04-29 | Downgrade | William Blair | Outperform to Market Perform | |
| 2016-04-29 | Downgrade | Raymond James | Outperform to Market Perform |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In EPAY 35 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 3.00M |
| BlackRock Institutional Trust Company, N.A. | 1.02M |
| BLACKROCK ADVISORS LLC | 0.56M |
| RUSSELL FRANK CO/ | 0.54M |
| OPPENHEIMER FUNDS INC | 0.34M |
| IndexIQ Advisors LLC | 0.29M |
| KALMAR INVESTMENTS INC /DE/ | 0.28M |
| BlackRock Investment Management, LLC | 0.24M |
| Netols Asset Management, Inc. | 0.23M |
| BlackRock Group LTD | 0.20M |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0.15M |
| Shinko Asset Management Co., Ltd. | 0.12M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.11M |
| Global X Management CO LLC | 0.10M |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 86645 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| EBERLE ROBERT A President and CEO | 0.87% (341410) | EPAY / |
| BARRY JOSEPH LEO JR | 0.38% (150061) | EPAY / |
| SAVORY NIGEL K Managing Director, Europe | 0.31% (122916) | EPAY / |
| Booth Richard Douglas Chief Financial Officer | 0.24% (95946) | EPAY / |
| LOOMIS JAMES L | 0.22% (84750) | EPAY / |
| DELUCA NORMAN J MD, Digital Banking | 0.22% (84675) | EPAY / |
| MULLEN JOSEPH L | 0.20% (77855) | EPAY / |
| DONOVAN KEVIN M Chief Financial Officer | 0.17% (66303) | EPAY / |
| Curran Michael J | 0.10% (39000) | EPAY / |
| MCGURL DANIEL M | 0.09% (37000) | EPAY / |
| Kelly John Francis GM, Legal Solutions | 0.08% (30008) | EPAY / |
| ZILINSKI JAMES W | 0.06% (25000) | EPAY / |
| D'Amato Ken | 0.05% (19000) | BHBK / EPAY / |
| Gibson Peter | 0.04% (17000) | EPAY / |
| Robinson Benjamin E III | 0.03% (13000) | EPAY / |
| GRAY JENNIFER M | 0.03% (10000) | EPAY / |
| Hough Paul H | 0.02% (9000) | EPAY / |
| LEATHE JEFFREY C | 0.01% (5000) | EPAY / |